Bolt Biotherapeutics Inc Sustainability Reports
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel immunotherapies for the treatment of cancer. The company utilizes its proprietary technology platform to engineer immune-stimulating antibody conjugates designed to target tumor cells and trigger anti-tumor immune cascades.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 254900W0P77PQ6B8OY50
FIGI: BBG00N8MY5W8
4 reports from 2020 to 2024
